General Notices

• Request for Information: Soliciting Input on Areas of Health Disparities and Inequities in Neurological Disease and/or Care in the United States Across the Lifespan
  (NOT-NS-20-026)
  National Institute of Neurological Disorders and Stroke
  

Notice of Changes to Funding Opportunities

• Notice of Early Expiration of NIDDK R21 Funding Opportunity Announcements
  (NOT-DK-20-016)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice to Extend the Application Due Date for RFA-FD-20-026 "Cooperative Agreement for Data Collection on Antimicrobial Use in Dogs and Cats (U01) Clinical Trials Not Allowed"
  (NOT-FD-20-022)
  Food and Drug Administration
  

• Notice to extend the 2020 Application Due Date for PAR-20-132 "Development and Maintenance of the Animal Feed Regulatory Program Standards with Optional Coordinated Preventive Control Regulatory Activities and Capacity Building (U18)"
  (NOT-FD-20-023)
  Food and Drug Administration
  

• Notice to Extend the 2020 Application Due Date for PAR-20-124 "NARMS Cooperative Agreement Program to Enhance and Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01)"
  (NOT-FD-20-024)
  Food and Drug Administration
  

• Notice of NICHD Participation in PAR 20-125 "Native American Research Centers for Health (NARCH) (S06 Clinical Trials Optional)"
  (NOT-HD-20-011)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of NHGRIs Participation in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)"
  (NOT-HG-20-034)
  National Human Genome Research Institute
  

• Notice of Participation of the National Institute on Minority Health and Health Disparities (NIMHD) in PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)
  (NOT-MD-20-018)
  National Institute on Minority Health and Health Disparities
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Administrative Supplements for Development of Training Modules in Genomic Medicine for Health Care Professionals
  (NOT-HG-20-020)
  National Human Genome Research Institute
  National Center for Advancing Translational Sciences
  

• Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
  (NOT-HG-20-030)
  National Human Genome Research Institute
  

• Notice of Special Interest (NOSI): Mental Health Comorbidities in HIV Prevention and Treatment
  (NOT-MH-20-013)
  National Institute of Mental Health
  

• Notice of Special Interest: Stigma or Other Social Determinants of Health (SDOH) in HIV Prevention and Treatment
  (NOT-MH-20-020)
  National Institute of Mental Health
  

• Notice of Special Interest (NOSI): Strengthening the HIV Care Continuum
  (NOT-MH-20-023)
  National Institute of Mental Health
  

• Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
  (NOT-MH-20-024)
  National Institute of Mental Health
  

• Notice of Special Interest: Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults
  (NOT-MH-20-035)
  National Institute of Mental Health
  

Funding Opportunities

• Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional)
  (PAR-20-152)
  National Eye Institute
  Application Receipt Date(s): April 20, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  
  

• NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)
  (PAR-20-153)
  National Institute of General Medical Sciences
  Application Receipt Date(s): July 14, 2020; July 13, 2021; July 13, 2022,by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
  
  

• Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
  (PAR-20-154)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 5, 2020.
  
  

• Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
  (PAR-20-155)
  National Cancer Institute
  National Institute of Biomedical Imaging and Bioengineering
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 5, 2020
  
  

• Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional)
  (PAR-20-156)
  National Institute on Aging
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 5, 2020.
  
  

• Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
  (PAR-20-157)
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 5, 2020
  
  

• Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)
  (PAR-20-158)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
  
  

• Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
  (PAR-20-159)
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 16, 2020
  
  

• Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
  (PAS-20-160)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Standard dates apply.
  
  

• Tuberculosis Research Units (U19 Clinical Trial Optional)
  (RFA-AI-20-020)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): September 28, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Cooperative Agreement to Support an Evidence-based Clinical Practice Guideline for the Treatment of Acute Dental Pain (U01) Clinical Trials Not Allowed
  (RFA-FD-20-029)
  Food and Drug Administration
  Application Receipt Date(s): June 1, 2020 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
  
  

• Cooperative Agreement to Support FDA Land and Water Initiative (U01) Clinical Trial Not Allowed
  (RFA-FD-20-034)
  Food and Drug Administration
  Application Receipt Date(s): June 1, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
  
  

• Child Health Research Career Development Award (CHRCDA) Program (K12 Clinical Trial Not Allowed)
  (RFA-HD-21-017)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): July 30, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional)
  (RFA-NS-20-029)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  Office of Research on Women's Health
  Application Receipt Date(s): July 14, 2020 and June 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.